Heyholder
‹ Activism Filings

DuChemBio Co, LTD Q3 profit from the main business KRW 1.9 billion on sales of KRW 11.0 billion

DuChemBio Co, LTD· Periodic Report

AI summary · Not investment advice

Dukembio sold KRW 11.0 billion in Q3 and earned KRW 1.9 billion from its main business, down 0.2% from a year earlier and 1.8% from the prior quarter.

Operating profit · 3 months

KRW 1.9 billion

Key facts

Revenue (3 months)
KRW 11.0 billion
Net income (3 months)
KRW 1.5 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 9.9 billion
Revenue (year to date)
KRW 31.9 billion
Operating profit (prior-year 3 months)
KRW 1.9 billion
Operating profit (year to date)
KRW 5.1 billion
Net income (prior-year 3 months)
KRW 1.4 billion
Net income (year to date)
KRW 3.6 billion

Commentary

AI commentary · Not investment advice

What happened

Dukem Bio reported its consolidated results for the third quarter of 2026 in its quarterly report. Sales for the 3 months were KRW 11.02 billion. That is 11.1% more than the same 3 months a year earlier (KRW 9.93 billion) and 1.5% less than the previous quarter.

In the company's terms

Operating profit (profit from the core business) for the 3 months was KRW 1.90 billion. It fell 0.2% from a year earlier (KRW 1.90 billion) and fell 1.8% from the previous quarter. Net income (final profit after taxes and other costs) for the 3 months was KRW 1.55 billion. It rose 7.7% from a year earlier (KRW 1.43 billion) and rose 28.3% from the previous quarter.

What changes for shareholders

For the year so far (January 1 to September 30), sales were KRW 31.92 billion. Operating profit was KRW 5.08 billion. Net income was KRW 3.62 billion.

Comments

No comments yet

Comments from shareholders will appear here.